Literature DB >> 16365819

Hepatolithiasis and intrahepatic cholangiocarcinoma: carcinogenesis based on molecular mechanisms.

Tamotsu Kuroki1, Yoshitsugu Tajima, Takashi Kanematsu.   

Abstract

Hepatolithiasis is more frequently seen in East Asian countries than in Western countries, and it is well known to represent a high-risk state for intrahepatic cholangiocarcinoma. Intrahepatic cholangiocarcinoma is an aggressive tumor that shows a dismal outcome even after resection. Cancer results from multistep carcinogenesis; however, the precise molecular mechanisms involved in the genetic alterations in cancer remain unknown. The accumulation of alterations in cancer-related genes leads to disruptions in cell-cycle regulation and also to continuous cell proliferation. The present review provides an overview of cancer-related genes in intrahepatic cholangiocarcinogenesis arising in hepatolithiasis. Further study of molecular mechanisms in hepatolithiasis-related intrahepatic cholangiocarcinoma, and the delineation of the influence of the genes involved should lead to our understanding of cholangiocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16365819     DOI: 10.1007/s00534-005-1004-1

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  13 in total

1.  Bilateral liver resection for bilateral intrahepatic stones.

Authors:  Shao-Qiang Li; Li-Jian Liang; Yun-Peng Hua; Bao-Gang Peng; Dong Chen; Shun-Jun Fu
Journal:  World J Gastroenterol       Date:  2009-08-07       Impact factor: 5.742

2.  Diagnosis and surgical treatment of intrahepatic hepatolithiasis combined with cholangiocarcinoma.

Authors:  Qian D Zhu; Meng T Zhou; Qing Q Zhou; Hong Q Shi; Qi Y Zhang; Zheng P Yu
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

3.  Risk Factors for Cholangiocarcinoma After Initial Hepatectomy for Intrahepatic Stones.

Authors:  Ze-Wu Meng; Sheng-Hua Han; Jin-Hai Zhu; Liang-Yi Zhou; Yan-Ling Chen
Journal:  World J Surg       Date:  2017-03       Impact factor: 3.352

4.  Incidence and Prognosis of Subsequent Cholangiocarcinoma in Patients with Hepatic Resection for Bile Duct Stones.

Authors:  Hyun Jung Kim; Tae Uk Kang; Heather Swan; Min Ji Kang; Nayoung Kim; Hyeong Sik Ahn; Seon Mee Park
Journal:  Dig Dis Sci       Date:  2018-08-31       Impact factor: 3.199

Review 5.  Cholangiocarcinoma: new insights into disease pathogenesis and biology.

Authors:  Chiara Braconi; Tushar Patel
Journal:  Infect Dis Clin North Am       Date:  2010-12       Impact factor: 5.982

6.  Risk factors for hilar cholangiocarcinoma: a case-control study in China.

Authors:  Wen-Ke Cai; Hui Sima; Ben-Dong Chen; Guang-Shun Yang
Journal:  World J Gastroenterol       Date:  2011-01-14       Impact factor: 5.742

7.  Cholangiocarcinoma Risk as Long-term Outcome After Hepatic Resection in the Hepatolithiasis Patients.

Authors:  Hyo Jung Kim; Jae Seon Kim; Sang Jun Suh; Beom Jae Lee; Jong-Jae Park; Hong Sik Lee; Chang Duck Kim; Young-Tae Bak
Journal:  World J Surg       Date:  2015-06       Impact factor: 3.352

Review 8.  Hepatolithiasis and intrahepatic cholangiocarcinoma: A review.

Authors:  Hyo Jung Kim; Jae Seon Kim; Moon Kyung Joo; Beom Jae Lee; Ji Hoon Kim; Jong Eun Yeon; Jong-Jae Park; Kwan Soo Byun; Young-Tae Bak
Journal:  World J Gastroenterol       Date:  2015-12-28       Impact factor: 5.742

9.  Comparison of concomitant and subsequent cholangiocarcinomas associated with hepatolithiasis: Clinical implications.

Authors:  Chia-Cheng Lin; Ping-Yi Lin; Yao-Li Chen
Journal:  World J Gastroenterol       Date:  2013-01-21       Impact factor: 5.742

10.  Diagnosis of distal cholangiocarcinoma after the removal of choledocholithiasis.

Authors:  Yasuhiro Ito; Takeshi Kenmochi; Tomohisa Egawa; Shinobu Hayashi; Atsushi Nagashima; Yuko Kitagawa
Journal:  Gastroenterol Res Pract       Date:  2012-11-22       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.